英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：


请选择你想看的字典辞典：
单词字典翻译
Stockdove查看　Stockdove　在百度字典中的解释百度英翻中〔查看〕
Stockdove查看　Stockdove　在Google字典中的解释Google英翻中〔查看〕
Stockdove查看　Stockdove　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Pembrolizumab - Wikipedia
    In June 2024, the US FDA approved pembrolizumab with carboplatin and paclitaxel, followed by single-agent pembrolizumab, for adults with primary advanced or recurrent endometrial carcinoma
  • Pembrolizumab (Keytruda): Uses, Dosage, Side Effects Warning - Drugs. com
    What is pembrolizumab? Pembrolizumab (Keytruda) is an immunotherapy used to treat cancers, including types of non-small cell lung cancer (NSCLC), breast cancer, melanoma, head and neck cancer, and many more
  • Pembrolizumab - NCI - National Cancer Institute
    Pembrolizumab works by binding to the protein PD-1 on the surface of certain immune cells called T cells, which keeps cancer cells from suppressing the immune system
  • KEYTRUDA® (pembrolizumab) - Official Site
    Learn about KEYTRUDA® (pembrolizumab), an immunotherapy that works with your immune system to help fight certain cancers Visit the patient website
  • Pembrolizumab: Cancer Treatment Uses, Side Effects, Dosage
    Pembrolizumab is a type of targeted therapy that does not directly kill cancer cells but alters a specific cell mechanism that promotes cancer growth and spread Pembrolizumab works by stimulating the body’s own immune system to fight against cancer cells
  • Pembrolizumab (intravenous route) - Side effects uses
    Pembrolizumab injection is used alone to treat non-small cell lung cancer (NSCLC) that has spread, whose tumors express PD-L1 and do not have an abnormal EGFR or ALK gene in patients who have not received other cancer treatments
  • FDA approves pembrolizumab with paclitaxel for platinum-resistant . . .
    The recommended dose of pembrolizumab is 200 mg every three weeks or 400 mg every six weeks until disease progression, unacceptable toxicity, or up to 24 months
  • Pembrolizumab (Keytruda) - Cancer Research UK
    Pembrolizumab is a type of immunotherapy It is a treatment for a number of different types of cancer such as melanoma Find out about how you have it, possible side effects and other important information
  • Pembrolizumab - Chemocare
    PEMBROLIZUMAB (PEM broe LIZ ue mab) treats some types of cancer It works by helping your immune system slow or stop the spread of cancer cells It is a monoclonal antibody This medicine may be used for other purposes; ask your health care provider or pharmacist if you have questions COMMON BRAND NAME (S): Keytruda
  • Pembrolizumab - Memorial Sloan Kettering Cancer Center
    Pembrolizumab Adult Medication This information from Lexicomp ® explains what you need to know about this medication, including what it’s used for, how to take it, its side effects, and when to call your healthcare provider





中文字典-英文字典  2005-2009